E-LIB Suche - Ergebnisse für: Nylén, Hanna

1

PREVALENCE AND RISK FACTORS FOR EFAVIRENZ-BASED ANTIRETROVI..:

Nylén, Hanna ; Habtewold, Abiy ; Makonnen, Eyasu...
BMJ Global Health. 2 (2017) Suppl 2 - p. A11.1-A11 , 2017

2

Effect of Statin Treatment on Plasma 4β‐Hydroxycholesterol ..:

Björkhem‐Bergman, Linda ; Nylén, Hanna ; Eriksson, Mats..
Basic & Clinical Pharmacology & Toxicology. 118 (2016) 6 - p. 499-502 , 2016

Link: https://doi.org/10.1111/..

3

miRNA‐27b levels are associated with CYP3A activity in vitr..:

Ekström, Lena ; Skilving, Ilona ; Ovesjö, Marie‐Louise...
Pharmacology Research & Perspectives. 3 (2015) 6 - p. , 2015

Link: https://doi.org/10.1002/..

4

Plasma Levels of 25‐Hydroxyvitamin D3 and In Vivo Markers o..:

Nylén, Hanna ; Björkhem‐Bergman, Linda ; Ekström, Lena...
Basic & Clinical Pharmacology & Toxicology. 115 (2014) 4 - p. 366-371 , 2014

Link: https://doi.org/10.1111/..

5

Quinine Compared to 4β-Hydroxycholesterol and Midazolam as ..:

Björkhem-Bergman, Linda ; Bäckström, Tobias ; Nylén, Hanna...
Drug Metabolism and Pharmacokinetics. 29 (2014) 4 - p. 352-355 , 2014

Link: https://doi.org/10.2133/..

6

A comparison of 4β‐hydroxycholesterol : cholesterol and 6β‐..:

Mårde Arrhén, Yvonne ; Nylén, Hanna ; Lövgren‐Sandblom, Anita...
British Journal of Clinical Pharmacology. 75 (2013) 6 - p. 1536-1540 , 2013

Link: https://doi.org/10.1111/..

7

Cytochrome P450 3A activity in mothers and their neonates a..:

Nylén, Hanna ; Sergel, Sofia ; Forsberg, Lisa...
European Journal of Clinical Pharmacology. 67 (2011) 7 - p. 715-722 , 2011

Link: https://doi.org/10.1007/..

8

4β‐hydroxycholesterol, an endogenous marker of CYP3A4/5 act..:

Diczfalusy, Ulf ; Nylén, Hanna ; Elander, Pontus.
British Journal of Clinical Pharmacology. 71 (2011) 2 - p. 183-189 , 2011

Link: https://doi.org/10.1111/..

9

Studies on 4b-hydroxycholesterol, a marker of CYP3A activit..:

Nylén, Hanna
I. Wide K, Larsson H, Bertilsson L, Diczfalusy U. Time course of the increase in 4β-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy. Br J Clin Pharmacol. 65, 708-715 (2008). ::doi::10.1111/j.1365-2125.2007.03078.x ::pmid::18279471 ::isi::000254930800012. , 2015

Link: http://hdl.handle.net/10..

10

Cytochrome P450 3A activity in mothers and their neonates a..:

Nylén, Hanna ; Sergel, Sofia ; Forsberg, Lisa...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00228-010-0984-1. , 2011

Link: https://hal.archives-ouv..

11

Studies on the oxysterols 4alpha- and 4beta-hydroxycholeste..:

Nylén, Hanna
I. Diczfalusy U, Nylén H, Elander P, Bertilsson L. 4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. Br J Clin Pharmacol. 71, 183-189 (2011). ::doi::10.1111/j.1365-2125.2010.03773.x ::pmid::21219398 ::isi::000286054600003. , 2011

Link: http://hdl.handle.net/10..

12

Effect of a mouth rinse and a high-fluoride toothpaste on c..:

Enerbäck, Hanna ; Lingström, Peter ; Möller, Marie...
American Journal of Orthodontics and Dentofacial Orthopedics. 162 (2022) 1 - p. 6-15.e3 , 2022

Link: https://doi.org/10.1016/..

13

Validation of caries risk assessment methods in orthodontic..:

Enerbäck, Hanna ; Lingström, Peter ; Möller, Marie...
American Journal of Orthodontics and Dentofacial Orthopedics. 158 (2020) 1 - p. 92-101.e3 , 2020

Link: https://doi.org/10.1016/..

14

Effects of orthodontic treatment and different fluoride reg..:

Enerbäck, Hanna ; Möller, Marie ; Nylén, Cathrine...
European Journal of Orthodontics. 41 (2018) 1 - p. 59-66 , 2018

Link: https://doi.org/10.1093/..

15

Number needed to vaccinate to prevent hospitalizations of p..:

Merk, Hanna ; Nylén, Gunnar ; Kühlmann-Berenzon, Sharon.
Vaccine. 32 (2014) 52 - p. 7135-7140 , 2014

Link: https://doi.org/10.1016/..